306 related articles for article (PubMed ID: 27531277)
1. Omega-3 fatty acid supplementation influences the whole blood transcriptome in women with obesity, associated with pro-resolving lipid mediator production.
Polus A; Zapala B; Razny U; Gielicz A; Kiec-Wilk B; Malczewska-Malec M; Sanak M; Childs CE; Calder PC; Dembinska-Kiec A
Biochim Biophys Acta; 2016 Nov; 1861(11):1746-1755. PubMed ID: 27531277
[TBL] [Abstract][Full Text] [Related]
2. Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors.
Keelan JA; Mas E; D'Vaz N; Dunstan JA; Li S; Barden AE; Mark PJ; Waddell BJ; Prescott SL; Mori TA
Reproduction; 2015 Feb; 149(2):171-8. PubMed ID: 25504868
[TBL] [Abstract][Full Text] [Related]
3. Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake.
Poulsen RC; Gotlinger KH; Serhan CN; Kruger MC
Am J Hematol; 2008 Jun; 83(6):437-45. PubMed ID: 18429055
[TBL] [Abstract][Full Text] [Related]
4. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study.
Grytten E; Laupsa-Borge J; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK
Clin Nutr; 2021 May; 40(5):2556-2575. PubMed ID: 33933722
[TBL] [Abstract][Full Text] [Related]
5. A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats.
Liu HQ; Qiu Y; Mu Y; Zhang XJ; Liu L; Hou XH; Zhang L; Xu XN; Ji AL; Cao R; Yang RH; Wang F
Nutr Res; 2013 Oct; 33(10):849-58. PubMed ID: 24074743
[TBL] [Abstract][Full Text] [Related]
6. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.
Rasic-Milutinovic Z; Perunicic G; Pljesa S; Gluvic Z; Sobajic S; Djuric I; Ristic D
Ren Fail; 2007; 29(3):321-9. PubMed ID: 17497447
[TBL] [Abstract][Full Text] [Related]
7. Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation.
Norris PC; Skulas-Ray AC; Riley I; Richter CK; Kris-Etherton PM; Jensen GL; Serhan CN; Maddipati KR
Sci Rep; 2018 Dec; 8(1):18050. PubMed ID: 30575798
[TBL] [Abstract][Full Text] [Related]
8. Over-the-counter fish oil supplementation and pro-resolving and pro-inflammatory lipid mediators in rheumatoid arthritis.
Marchand NE; Choi MY; Oakes EG; Cook NR; Stevens E; Gomelskaya N; Kotler G; Manson JE; Lasky-Su J; Mora S; Lee IM; Tatituri R; Costenbader KH
Prostaglandins Leukot Essent Fatty Acids; 2023 Mar; 190():102542. PubMed ID: 36773395
[TBL] [Abstract][Full Text] [Related]
9. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS.
Hartling I; Cremonesi A; Osuna E; Lou PH; Lucchinetti E; Zaugg M; Hersberger M
Clin Chem Lab Med; 2021 Oct; 59(11):1811-1823. PubMed ID: 34243224
[TBL] [Abstract][Full Text] [Related]
10. No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial.
Hoogeveen EK; Geleijnse JM; Kromhout D; Giltay EJ
Eur J Prev Cardiol; 2014 Nov; 21(11):1429-36. PubMed ID: 23774275
[TBL] [Abstract][Full Text] [Related]
11. Modification of subcutaneous white adipose tissue inflammation by omega-3 fatty acids is limited in human obesity-a double blind, randomised clinical trial.
Fisk HL; Childs CE; Miles EA; Ayres R; Noakes PS; Paras-Chavez C; Kuda O; Kopecký J; Antoun E; Lillycrop KA; Calder PC
EBioMedicine; 2022 Mar; 77():103909. PubMed ID: 35247847
[TBL] [Abstract][Full Text] [Related]
12. Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial.
See VHL; Mas E; Prescott SL; Beilin LJ; Burrows S; Barden AE; Huang RC; Mori TA
Br J Nutr; 2017 Dec; 118(11):971-980. PubMed ID: 29173199
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation.
Weylandt KH; Chiu CY; Gomolka B; Waechter SF; Wiedenmann B
Prostaglandins Other Lipid Mediat; 2012 Mar; 97(3-4):73-82. PubMed ID: 22326554
[TBL] [Abstract][Full Text] [Related]
14. Health benefits of n-3 polyunsaturated fatty acids: eicosapentaenoic acid and docosahexaenoic acid.
Siriwardhana N; Kalupahana NS; Moustaid-Moussa N
Adv Food Nutr Res; 2012; 65():211-22. PubMed ID: 22361189
[TBL] [Abstract][Full Text] [Related]
15. Effects of a supplementation of n-3 polyunsaturated fatty acids with or without fish gelatin on gene expression in peripheral blood mononuclear cells in obese, insulin-resistant subjects.
Rudkowska I; Ponton A; Jacques H; Lavigne C; Holub BJ; Marette A; Vohl MC
J Nutrigenet Nutrigenomics; 2011; 4(4):192-202. PubMed ID: 21876360
[TBL] [Abstract][Full Text] [Related]
16. [Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids].
Nowak JZ
Postepy Hig Med Dosw (Online); 2010 Mar; 64():115-32. PubMed ID: 20354260
[TBL] [Abstract][Full Text] [Related]
17. Effect of Omega-3 Fatty Acid Supplementation on Oxylipins in a Routine Clinical Setting.
Schmöcker C; Zhang IW; Kiesler S; Kassner U; Ostermann AI; Steinhagen-Thiessen E; Schebb NH; Weylandt KH
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29316682
[TBL] [Abstract][Full Text] [Related]
18. Generation and dietary modulation of anti-inflammatory electrophilic omega-3 fatty acid derivatives.
Cipollina C; Salvatore SR; Muldoon MF; Freeman BA; Schopfer FJ
PLoS One; 2014; 9(4):e94836. PubMed ID: 24736647
[TBL] [Abstract][Full Text] [Related]
19. EPA and DHA differentially modulate monocyte inflammatory response in subjects with chronic inflammation in part via plasma specialized pro-resolving lipid mediators: A randomized, double-blind, crossover study.
So J; Wu D; Lichtenstein AH; Tai AK; Matthan NR; Maddipati KR; Lamon-Fava S
Atherosclerosis; 2021 Jan; 316():90-98. PubMed ID: 33303222
[TBL] [Abstract][Full Text] [Related]
20. Dietary n-3 long chain PUFA supplementation promotes a pro-resolving oxylipin profile in the brain.
Rey C; Delpech JC; Madore C; Nadjar A; Greenhalgh AD; Amadieu C; Aubert A; Pallet V; Vaysse C; Layé S; Joffre C
Brain Behav Immun; 2019 Feb; 76():17-27. PubMed ID: 30086401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
